Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer.
BACKGROUND: The Collaborative Group on Hormonal Factors in Breast Cancer has brought together and reanalysed about 90% of the worldwide epidemiological evidence on the relation between risk of breast cancer and use of hormone replacement therapy (HRT). METHODS: Individual data on 52,705 women with b...
主要作者: | Beral, V |
---|---|
格式: | Journal article |
語言: | English |
出版: |
1997
|
相似書籍
-
Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer
由: Beral, V, et al.
出版: (1997) -
Breast cancer and hormonal contraceptives: further results. Collaborative Group on Hormonal Factors in Breast Cancer.
由: Beral, V
出版: (1996) -
Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies. Collaborative Group on Hormonal Factors in Breast Cancer.
由: Cancer, C
出版: (1996) -
Breast cancer and hormonal contraceptives: Collaborative reanalysis of individual data on 53297 women with breast cancer and 100239 women without breast cancer from 54 epidemiological studies
由: Calle, E, et al.
出版: (1996) -
Breast cancer and combined oral contraceptives: Results from the Collaborative Group on Hormonal Factors in Breast Cancer
由: Beral, V, et al.
出版: (1998)